| Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation S Hamarsheh, L Osswald, BS Saller, S Unger, D De Feo, JM Vinnakota, ... Nature communications 11 (1), 1-17, 2020 | 124 | 2020 |
| Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia N El Khawanky, A Hughes, W Yu, R Myburgh, T Matschulla, S Taromi, ... Nature communications 12 (1), 6436, 2021 | 83 | 2021 |
| Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia NR Mathew, JM Vinnakota, P Apostolova, D Erny, S Hamarsheh, ... The Journal of clinical investigation 130 (3), 1315-1329, 2020 | 58 | 2020 |
| Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation JNHG Ho, D Schmidt, T Lowinus, J Ryoo, EP Dopfer, N Gonzalo Núñez, ... Blood, The Journal of the American Society of Hematology 140 (10), 1167-1181, 2022 | 36 | 2022 |
| Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome JM Vinnakota, F Biavasco, M Schwabenland, C Chhatbar, RC Adams, ... Nature cancer 5 (8), 1227-1249, 2024 | 13 | 2024 |
| Two c-Myc binding sites are crucial in upregulating the expression of human phospholipid scramblase 1 gene JM Vinnakota, SN Gummadi Biochemical and Biophysical Research Communications 469 (3), 412-417, 2016 | 11 | 2016 |
| Anti–PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation JM Vinnakota, RC Adams, D Athanassopoulos, D Schmidt, F Biavasco, ... Science translational medicine 16 (751), eadj9672, 2024 | 8 | 2024 |
| Acute Graft-Versus-Host Disease, Infections, Vascular Events and Drug Toxicities Affecting the Central Nervous System JM Vinnakota, R Zeiser Frontiers in immunology 12, 748019, 2021 | 8 | 2021 |
| CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice RC Adams, D Carter-Cusack, GT Llanes, CR Hunter, JM Vinnakota, ... Blood 143 (10), 912-929, 2024 | 7 | 2024 |
| ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease K Maas-Bauer, AV Stell, KL Yan, E de Vega, JM Vinnakota, S Unger, ... Nature communications 15 (1), 446, 2024 | 6 | 2024 |
| Oncogenic Kras (G12D) causes myeloproliferation via NLRP3 inflammasome activation. Nat. Commun. 11, 1659 S Hamarsheh, L Osswald, BS Saller, S Unger, D De Feo, JM Vinnakota, ... | 5 | 2020 |
| Immune-effector-cell-associated-neurotoxicity-syndrome (ICANS) pathophysiology is mediated by microglia TGF-β-activated kinase-1 signaling JM Vinnakota, F Biavasco, M Schwabenland, C Chhatbar, RC Adams, ... Blood 142 (Supplement 1), 100-100, 2023 | 2 | 2023 |
| Patient‐derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma LK Isbell, C Tschuch, S Doostkam, S Waldeck, G Andrieux, ... Neuropathology and Applied Neurobiology 49 (2), e12899, 2023 | 2 | 2023 |
| Snail represses the expression of human phospholipid scramblase 4 gene JM Vinnakota, SN Gummadi Gene 591 (2), 433-441, 2016 | 2 | 2016 |
| Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment D Schmidt, C Endres, R Hoefflin, G Andrieux, M Zwick, N Karantzelis, ... Cancer research 84 (18), 2985-3003, 2024 | 1 | 2024 |
| 6-Formylindolo (3, 2-b) carbazole ameliorates Graft-versus-Host Disease of the central nervous system via arylhydrocarbon receptor/NF-κB pathway in microglia AJ Zaehringer, S Chatterjee, JM Vinnakota, D Erny, RC Adams, J Gawron, ... European Journal of Immunology 54, 72-72, 2024 | | 2024 |
| Targeting TAK1 in microglia to treat CAR T cell neurotoxicity JM Vinnakota, R Zeiser NATURE CANCER 5 (6), 953-953, 2024 | | 2024 |
| Immuntherapie für Leukämie sicherer und wirksamer machen JM Vinnakota TumorDiagn u Ther 45, 2024 | | 2024 |
| Role of linoleic acid in acute Graft-versus-Host Disease (aGvHD) V Wenger, M Czech, JM Vinnakota, D Schmidt, E Haring, P Apostolova, ... ONCOLOGY RESEARCH AND TREATMENT 46, 86-86, 2023 | | 2023 |
| Neurological Complications Associated with Cancer Immunotherapies-Allogeneic Stem Cell Transplantation, Immune Checkpoint Inhibition, and CAR T Cell Therapy JM Vinnakota Albert-Ludwigs-Universität Freiburg, 2022 | | 2022 |
